Skip to main content

Peer Review reports

From: NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma

Original Submission
16 Oct 2023 Submitted Original manuscript
30 Jan 2024 Reviewed Reviewer Report - Antonio Romallo
2 Mar 2024 Reviewed Reviewer Report
16 Mar 2024 Author responded Author comments - Xin Chen
22 Mar 2024 Author responded Author comments - Xin Chen
Resubmission - Version 2
16 Mar 2024 Submitted Manuscript version 2
29 Mar 2024 Author responded Author comments - Xin Chen
Resubmission - Version 3
29 Mar 2024 Submitted Manuscript version 3
5 Apr 2024 Author responded Author comments - Xin Chen
Resubmission - Version 4
5 Apr 2024 Submitted Manuscript version 4
Publishing
6 May 2024 Editorially accepted
19 May 2024 Article published 10.1186/s12890-024-03046-1

You can find further information about peer review here.

Back to article page